Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development
Search Refinements
Search Results: Drug Discovery & Development
1-15 of 4947 results
Biovian at BIO-Europe Spring March 9-11, 2015
Biovian's CEO, Dr. Knut Ringbom will be available for in-depth discussions with your delegates at the partnering offered at the conference.
Drug Research > Drug Discovery & Development > Press Releases
BioLineRx seeks German approval to begin Phase IIb trial of leukemia drug candidate BL-8040
By PBR Staff Writer
Israeli biopharmaceutical firm BioLineRx has submitted regulatory applications to the German Federal Institute for Drugs and Medical Devices (BfArM) seeking approval to begin a Phase IIb trial of its clinical-stage drug candidate BL-8040 as a new consolidation treatment for acute myeloid leukemia (AML).
Drug Research > Drug Discovery & Development > News
Alizé Pharma begins Phase II trial of AZP-531 to treat Prader-Willi syndrome
By PBR Staff Writer
France-based Alizé Pharma has started a Phase II clinical trial of AZP-531, its unacylated ghrelin analog, to treat patients with Prader-Willi syndrome, a rare genetic metabolic syndrome.
Drug Research > Drug Discovery & Development > News
CEL-SCI gets clearance to conduct Phase III trial of cancer drug Multikine in 21 countries
By PBR Staff Writer
US-based biotechnology firm CEL-SCI has received clearance from the Ministry of Health of the Republic of Belarus to begin patient enrollment in the Phase III trial of its investigational cancer immunotherapy Multikine (Leukocyte Interleukin, Injection) in Belarus to treat head and neck cancer.
Drug Research > Drug Discovery & Development > News
Triphase, Sunnybrook to advance development new bi-specific antibody for cancer patients
By PBR Staff Writer
US-based Triphase Accelerator has entered into an academic center collaboration with Canada's Sunnybrook Research Institute to advance development of its new, first-in-class, fully human bi-specific antibody TRPH 011 and evaluate the role of bifunctional targeting of VEGFR-2 and TIE 2 receptors in cancer patients.
Drug Research > Drug Discovery & Development > News
Modalities
Modalities include a dedicated device, a smartphone app and IWRS.
Drug Research > Drug Discovery & Development > Products
Respiratory Devices
Respiratory devices include: MasterScope® CT, FlowScreen® CT, AM3 ®, AM1+ ®, SpiroPro® CT and Clean Peak Flow Meter®.
Drug Research > Drug Discovery & Development > Products
ABPM Collection Devices
ABPM collection devices include the Mortara Ambulo™ 2400.
Drug Research > Drug Discovery & Development > Products
ECG Collection Devices
Products include: ELI-PC 12- Lead ECG, ELI 150, ELI 10, ELI 250, MAC 1200.
Drug Research > Drug Discovery & Development > Products
MedImmune, NIST partner to advance drug discovery and manufacturing
By PBR Staff Writer
AstraZeneca's biologics research and development arm MedImmune will partner with US Department of Commerce’s National Institute of Standards and Technology (NIST) to advance development of biological therapies.
Drug Research > Drug Discovery & Development > News
Takeda, UK’s QMUL partner to develop new therapies for gastrointestinal diseases
By PBR Staff Writer
Japan-based Takeda Pharmaceutical Company (Takeda) has entered into a research collaboration with Queen Mary University of London (QMUL) to define new insights and develop novel therapies for the treatment of gastrointestinal (GI) diseases.
Drug Research > Drug Discovery & Development > News
Alzheimer's Research UK launches £30m dementia drug discovery alliance
By PBR Staff Writer
Alzheimer's Research UK has launched a £30m Drug Discovery Alliance, which will see research centres use their expertise to discover drugs for dementia.
Drug Research > Drug Discovery & Development > News
Best Practices for Streamlining Electronic Implementation of Established COAs; Copyright January 2015
| By ERT
This paper addresses the best practices for building an electronic Clinical Outcome Assessment (eCOA) solution in support of clinical research as it relates to the operational and licensing compliance aspects of administering COAs on electronic platforms.
Drug Research > Drug Discovery & Development > White Papers
Symptoms and Impact of COPD Assessed by an Electronic Diary in Patients with Moderate-to-Severe COPD: Psychometric Results from the SHINE Study; International Journal of COPD; January 2015.
| By ERT
This paper presents the results of psychometric assessment data from a COPD eDiary developed by Novartis to provide a more detailed assessment of symptom frequency and severity and their impact on patients with COPD.
Drug Research > Drug Discovery & Development > White Papers

PBR Supplier Recommendations

ERT - Getting it done. Right.
ERT is a leading global provider of high-quality patient safety and efficacy endpoint data collection solutions for use by biopharmaceutical companies during clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle.... Drug Research > Drug Discovery & Development > Suppliers
Vetter Pharma International - High-Quality Aseptically Pre-Filled Injection Systems
From preclinical development through commercial supply.... Drug Research > Drug Discovery & Development > Suppliers
Biovian - cGMP Contract Manufacturing of Biopharmaceuticals
Biovian is a dynamic and effective new generation one-stop-shop CMO in cGMP contract manufacturing of biopharmaceuticals. Biovian's services cover the full range from antigen isolation, expression, vector construction, cell line cultivation, cGMP protein purification to product fill and finish.... Drug Research > Drug Discovery & Development > Suppliers
Tosoh Bioscience - Your Specialist in Separation
Tosoh Bioscience is an acknowledged global leader in the field of liquid chromatography with a strong focus on bioseparations. We offer solutions for research, drug discovery, clinical chemistry, environmental analysis, manufacturing and other industrial applications. ... Drug Research > Drug Discovery & Development > Suppliers
Medical Research Network - Clinical Trial Support Organisation
The Medical Research Network (MRN) is a unique clinical trial support organisation (CTSO). The MRN has been involved in the conduct of over 50 clinical trials across a wide range of therapeutic areas, in particular oncology and rheumatology.... Drug Research > Drug Discovery & Development > Suppliers
See more

PBR White Paper Recommendations

Best Practices for Streamlining Electronic Implementation of Established COAs; Copyright January 2015 By ERT
This paper addresses the best practices for building an electronic Clinical Outcome Assessment (eCOA) solution in support of clinical research as it relates to the operational and licensing compliance aspects of administering COAs on electronic platforms.... Drug Research > Drug Discovery & Development > White Papers Symptoms and Impact of COPD Assessed by an Electronic Diary in Patients with Moderate-to-Severe COPD: Psychometric Results from the SHINE Study; International Journal of COPD; January 2015. By ERT
This paper presents the results of psychometric assessment data from a COPD eDiary developed by Novartis to provide a more detailed assessment of symptom frequency and severity and their impact on patients with COPD.... Drug Research > Drug Discovery & Development > White Papers The Use of Ambulatory Blood Pressure Monitoring in Drug Development; Copyright, January 2015 By ERT
This white paper delves into the basics of blood pressure, along with the well-documented limitations of standard and digital office blood pressure measurements. It reviews ABPM device functionality, common drug classes where blood pressure monitoring comes into play and compares the advantages and disadvantages of different monitoring options in clinical studies.... Drug Research > Drug Discovery & Development > White Papers The Use of Continuous ECG Recordings (Holters) in Drug Development; Copyright, December 2014 By ERT
Continuous 12 lead ECG recorders, often referred to as Holter devices, offer specific advantages to be considered over the standard 12 lead ECGs often collected during clinical trials for cardiac safety. This white paper explores the history of Holters, how sponsors, sites, and patients use these devices, and the benefits of continuous ECG recordings.... Drug Research > Drug Discovery & Development > White Papers Predictive Value of Baseline electronic Columbia-Suicide Severity Rating Scale (eC-SSRS) Assessments for Identifying Risk of Prospective Reports of Suicidal Behavior During Clinical Research; Innovations in Clinical Neuroscience; November 2014 By ERT
This meta-analysis examined the ability of baseline eC-SSRS lifetime suicidal ideation and behavior categories to predict prospective reports of suicidal behavior in psychiatric and non-psychiatric research participants. The review of over 74,000 eC-SSRS assessments determined that increasingly more severe lifetime suicidal ideation at baseline was associated with a progressively greater likelihood of prospectively reported suicidal behavior during study participation.... Drug Research > Drug Discovery & Development > White Papers See more
1-15 of 4947 results